Cabıoğlu, N. Et Al. 2024. Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy. WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.22, no.1 .

Cabıoğlu, N., KARANLIK, H., Yılmaz, R., Emiroğlu, S., Tükenmez, M., BADEMLER, S., ... Şimşek, D. H.(2024). Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy. WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.22, no.1.

Cabıoğlu, Neslihan Et Al. "Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy," WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.22, no.1, 2024

Cabıoğlu, Neslihan Et Al. "Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy." WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.22, no.1, 2024

Cabıoğlu, N. Et Al. (2024) . "Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy." WORLD JOURNAL OF SURGICAL ONCOLOGY , vol.22, no.1.

@article{article, author={Neslihan Cabıoğlu Et Al. }, title={Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy}, journal={WORLD JOURNAL OF SURGICAL ONCOLOGY}, year=2024}